2018 NABP-AACP District I and II Meeting

Objectives

• Demonstrate a heightened awareness and knowledge of students with disabilities who enter professional degree programs.
• Using a case study, examine complex challenges facing educators and administrators in the provision of academic support for students with mental health challenges and disabilities.
• Interpret federal law as relates to students with disabilities and its translation and implementation of appropriate policies and procedures at institutions of higher learning.
• Examine proactive measures that can be taken to ensure appropriate testing accommodations and other types of academic support for students facing mental health challenges and/or disabilities.
• Differentiate the roles and responsibilities for Students, Faculty and Staff when interacting with students with disabilities.

Speaker(s)/Author(s)

Elaine Bourne-Heath, Ph.D. Howard University

Activity Number

0010-9999-18-010-L04-P

CE Hours

Objectives

• Describe the various avenues by which pharmacy technicians are entering the U.S. workforce today.
• Explain the variation in pharmacy technician education and accreditation requirements across U.S. state boards of pharmacy and the potential benefits of harmonization.
• Name key findings of the 2017 Pharmacy Technician Stakeholder Consensus Conference.
• List key differences in the new ASHP/ACPE Accreditation Standards for Pharmacy Technician Education and Training Programs from the current accreditation standards.

Speaker(s)/Author(s)

Janet Silvester, Pharm.D. ASHP

Activity Number

0010-9999-18-011-L04-P

CE Hours

Location

Objectives

• Explain why telepharmacy started and how it has evolved with technology.
• List the different types of telepharmacy and how its use is improving patient care.
• Describe the telpharmacy regulatory environment around the United States and what states are doing with rules.

Speaker(s)/Author(s)

Jessica Adams, Pharm.D.

Activity Number

0010-9999-18-012-L04-P

CE Hours

Objectives

• Compare and contrast three techniques used in pharmaceutical marketing.
• Illustrate how pharmaceutical industry marketing practices contributed to the opioid epidemic.
• Examine three examples of misinformation about opioids.

Speaker(s)/Author(s)

Adriane Fugh-Berman, MD Georgetown Univ. Med. Center

Activity Number

0010-9999-18-013-L04-P

CE Hours

Objectives

• Examine the epidemiology of opioid use disorder and opioid overdose in the United States.
• Analyze available treatment options for opioid use disorder and illustrate potential barriers for adequate treatment in this patient population.
• Compare and contrast solutions to address current limitations related to prevention of fatal opioid overdoses and the treatment of opioid use disorder.

Speaker(s)/Author(s)

Jasmine Carpenter, PharmD, BCPS Mental Health Clinical Pharmacy Specialist, DC Veterans Affairs Medical Center

Activity Number

0010-9999-18-014-L04-P

CE Hours

Location